Here are four takeaways:
1. In the procedure for dropless surgery, the surgeon places medication (antibiotics or steroids) in or around the eye at the time of surgery to reduce or eliminate the need for postoperative eyedrops.
2. According to Jeffrey Todd Liegner, MD, dropless surgery improves prophylaxis against infection, offers preemptive control of inflammation in the hands of the surgeon, provides better therapeutic compliance, entails less overall cost to the patient and insurer and simplifies communication with the patient about postoperative care.
3. Dr. Liegner said the product that provides the greatest ease of use, less waste and lowest risk for contamination or complication is a compound drug made of a long-acting steroid and an effective broad spectrum antibiotic, with coverage for gram-positive organisms, also known as Tri-Moxi and Tri-Moxi-Vanc.
4. Compared with eye drops, dropless cataract surgery carries a greatly-reduced risk for endophthalmitis, an inflammation of the internal coats of the eye.
More articles on healthcare:
24 things to know about AmSurg
AmSurg acquires Northside Anesthesiology Consultants, Tenet updates outlook for 2015 revenue to $18.5B & more — 5 key notes on ASC companies
Catherine Compton transfers to Winona Health’s Plastic, Cosmetic and Reconstructive Surgery department — 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
